As expected, the APOE‐Ɛ4 allele frequency was higher in the AD cohort than in controls (52.3% vs. 18.1%, respectively; p < 0.001; OR [95% CI]: 4.96 [3.87‐6.38]) (Table S1). This evidence concerns the gene APOE and Alzheimer disease.